May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Candidate Gene Screening for Posterior Polymorphous Dystrophy
Author Affiliations & Notes
  • A.J. Aldave
    Cornea Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • V.S. Yellore
    Cornea Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • A.H. Principe
    Cornea Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • G. Abedi
    Cornea Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • K. Merrill
    Cornea Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • I. Raber
    Cornea Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA
  • K.W. Small
    Retina Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • N. Udar
    Retina Service,
    The Jules Stein Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  A.J. Aldave, None; V.S. Yellore, None; A.H. Principe, None; G. Abedi, None; K. Merrill, None; I. Raber, None; K.W. Small, None; N. Udar, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1526. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.J. Aldave, V.S. Yellore, A.H. Principe, G. Abedi, K. Merrill, I. Raber, K.W. Small, N. Udar; Candidate Gene Screening for Posterior Polymorphous Dystrophy . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1526.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To perform candidate gene screening for posterior polymorphous corneal dystrophy (PPCD). The initial three genes chosen, ID1, BCL2L1 and VSX1, lie within the region on chromosome 20 to which the PPCD gene has been linked, and mutations in VSX1 have previously been identified in patients with PPCD. Methods: DNA extraction, PCR amplification and direct sequencing of the VSX1, BCL2L1 and ID1 genes was performed in 18 affected patients (14 families) as well as in unaffected family members and healthy control individuals. Results: No coding region mutations in the BCL2L1 or the ID1 genes were identified in affected patients. In the VSX1 gene, the previously identified Gly160Asp missense change was not present in any of our 14 probands, and the Asp144Glu mutation was identified in 1 affected patient as well as 1 unaffected control individual. Additionally, 3 synonymous substitutions, Ala182Ala, Gly239Gly and Asp323Asp, were identified in 11 affected patients and 1 unaffected patient from 9 families, 1 affected patient and 1 unaffected patient from the same family, and 1 affected patient, respectively. In the ID1 gene, the synonymous substitution Gly216Gly was observed in 2 affected patients (2 families), who also demonstrated a single nucleotide change in both the 5’UTR (2129T>C) and 3’UTR (3267A>G). Another 5’UTR change, 2177T>C, was identified in 1 affected patient and his unaffected parent, both of whom also demonstrated the 2129T>C and 3267A>G changes. Conclusions: None of the 14 probands with PPCD demonstrated the previously described Gly160Asp mutation within the VSX1 gene. The Asp144Glu missense change, present in an affected patient as well as an unaffected control individual, appears to be a rare polymorphism, not a disease causing mutation. No coding region changes were identified in the ID1 or BCL2L1 genes. Therefore, although we report a number of novel polymorphisms in the VSX1 and ID1 genes, the failure to identify any sequence variants that sort with the disease phenotype suggests that other genetic factors are involved in PPCD.

Keywords: cornea: endothelium • gene screening • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×